KDIGO Releases New FSGS Podcast Series

Episode 31 (#1 of 3) – The Podocyte Problem: Understanding FSGS

Dr. Campbell speaks with Alessia Fornoni, MD (University of Miami, US), about the evolving understanding of FSGS as a podocytopathy driven by podocyte injury. The discussion explores advances in FSGS classification, the role of angiotensin II and endothelin-1 signaling in disease progression, emerging insights into disease mechanisms, and how new targeted therapies may help preserve podocyte function and slow the progression of kidney disease.

Episode 32 (#2 of 3) – Proteinuria First: Managing What Matters in FSGS

Dr. Campbell speaks with Dr. Laura Mariani (University of Michigan, US) about the central role of proteinuria reduction in the management of FSGS. The episode explores the biologic link between podocyte injury and proteinuria, the goals and findings of the PARASOL initiative, and how proteinuria may help guide clinical trial design and treatment decisions in FSGS.

Episode 33 (#3 of 3) – Treating FSGS: From Steroids to Dual Endothelin Angiotensin Receptor Antagonists and What Comes Next

Dr. Campbell speaks with Dr. Jai Radhakrishnan (Columbia University, US) about the evolving management of proteinuric FSGS. The discussion explores diagnostic and classification challenges, the role of supportive care and immunosuppression, emerging podocyte-targeted therapies, and the growing shift toward precision medicine in FSGS care.